Literature DB >> 10346422

Common errors and controversies in pharmacoeconomic analyses.

J Soto1.   

Abstract

Mesh：

Year:  1998        PMID： 10346422     DOI： 10.2165/00019053-199814060-00012

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  11 in total

Review 1.  Common errors and controversies in pharmacoeconomic analyses.

Authors:  S Byford; S Palmer
Journal:  Pharmacoeconomics       Date:  1998-06       Impact factor: 4.981

2.  Economic analysis alongside clinical trials. Bias in the assessment of economic outcomes.

Authors:  L B Ellwein; M F Drummond
Journal:  Int J Technol Assess Health Care       Date:  1996       Impact factor: 2.188

3.  Why we need observational studies to evaluate the effectiveness of health care.

Authors:  N Black
Journal:  BMJ       Date:  1996-05-11

4.  Generalisation from phase III clinical trials: survival, quality of life, and health economics.

Authors:  P M Fayers; D J Hand
Journal:  Lancet       Date:  1997-10-04       Impact factor: 79.321

5.  A review of methodologies for assessing drug effectiveness and a new proposal: randomized database studies.

Authors:  J A Sacristán; J Soto; I Galende; T R Hylan
Journal:  Clin Ther       Date:  1997 Nov-Dec       Impact factor: 3.393

6.  Modelling in economic evaluation: an unavoidable fact of life.

Authors:  M J Buxton; M F Drummond; B A Van Hout; R L Prince; T A Sheldon; T Szucs; M Vray
Journal:  Health Econ       Date:  1997 May-Jun       Impact factor: 3.046

Review 7.  Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials?

Authors:  B O'Brien
Journal:  Med Care       Date:  1996-12       Impact factor: 2.983

8.  Can overall results of clinical trials be applied to all patients?

Authors:  P M Rothwell
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321

9.  Cost-effectiveness comparisons using "real world" randomized trials: the case of new antidepressant drugs.

Authors:  G Simon; E Wagner; M Vonkorff
Journal:  J Clin Epidemiol       Date:  1995-03       Impact factor: 6.437

10.  Problems of clinical trials as evidence of therapeutic effectiveness.

Authors:  E Hemminki
Journal:  Soc Sci Med       Date:  1982       Impact factor: 4.634
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.